OEM News

Exactech Wins FDA Nod for Truliant Porous 3D Tibial Implant

The porous tibial tray leverages additive manufacturing technology for a porous structure that mimics the structure of cancellous bone.

Author Image

By: Sam Brusco

Associate Editor

Truliant porous 3D tibial implant for knee replacement surgery. Photo: Exactech.

Exactech has earned U.S. Food and Drug Administration (FDA) 510(k) clearance for its Truliant porous tibial tray, a 3D-printed tibial knee implant.

The Truliant porous tibial tray leverages additive manufacturing technology for a porous structure that mimics the structure of cancellous bone. This design, according to the company, aims to help along both initial and biological fixation, in order to accommodate active lifestyles.

The laser-printed 3D tibial tray touts peripherally placed tibial pegs, a dual v-channeled keel, and optional cancellous bone screws that were designed to boost initial rotational stability and permit an increased bone-implant interface.

The FDA clearance positions Exactech to continue to address the rising demand for cementless knee solutions.

“With a focus on cementless fixation and increased efficiency, it is no surprise that Truliant Porous is the fastest growing segment of Exactech’s knee portfolio,” said Exactech chief marketing officer and senior VP of Large Joints Adam Hayden. “By expanding our porous offerings with the laser-printed tray, knee surgeons will have access to additional sizing and fixation options for the personalization of their patients’ total knee replacement procedures, improving upon Exactech’s already successful cementless knee.”

Last week, the company successfully completed the first ankle replacement using its new Vantage Ankle 3D and 3D+ tibial implants.

Keep Up With Our Content. Subscribe To Orthopedic Design & Technology Newsletters